$15.90▼-0.18 (-1.12%)
After Hours:$15.82-0.08 (-0.50%)
Ultragenyx Pharmaceutical Inc. (RARE)
Operating Expenses
$1.07B
TTM · Period ending: · USD

RARE Operating Expenses
Latest reported$1.07Bperiod ending
Latest reported$1.07Bperiod ending
RARE Operating Expenses ($6.56M → $1.07B)
Annual operating expenses
High-resolution chart · PNG
What is operating expenses?
Expenses from normal business operations (SG&A, R&D, etc.).
RARE operating expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| 1,099,000,000 | |
| 1,019,475,000 | |
| 958,248,000 | |
| 983,928,000 | |
| 717,135,000 | |
| 595,017,000 | |
| 518,879,000 | |
| 421,722,000 | |
| 331,553,000 | |
| 248,140,000 | |
| 147,738,000 | |
| 56,778,000 | |
| 32,280,000 | |
| 15,985,000 | |
| 6,561,000 |
Explore More
RARE Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance